Sensyne Health Plc (LON: SENS) has become a Strategic Partner of Microsoft after extending its existing association with the tech company.
- The UK Clinical AI company, along with Microsoft, will work to further develop and refine its clinical AI and health cloud technologies.
- The association will supportSensyneto improve, augment, and reduce the cost of patient care.
- It will also enhance the capabilityof the company to create accessible and highly configurable healthcare technologies that are universally deployable and able to meet local, clinical, and regulatory needs.
- On 28 October 2020, the stocks of the company surgedby 10.85% from its previous closing, hovering at around GBX 117.50at 08:13 AM GMT+1.